Anxiety

5th October 20196th October 2019Immo Weichert

Cognitive behavioural therapy delivered by respiratory nurses is clinically effective and cost-effective for patients with chronic obstructive pulmonary disease and symptoms of anxiety

This is a randomised controlled trial that was published in 2018. [1] A total of 236 patients with a diagnosis of mild to very severe COPD took part in the trial. Each patient was screened for anxiety using the HADS-Anxiety Subscale. This is a questionnaire that asks patients about their feelings of anxiety and depression…

2nd October 20192nd October 2019Immo Weichert

Anxiety and depression in renal disease

This is a narrative review that was published in 2018. [1] The authors there describe the evidence surrounding psychiatric comorbidity in patients with kidney disease, including the effect on progression and mortality. 1 Goh ZS, Griva K. Anxiety and depression in patients with end-stage renal disease: Impact and management challenges – A narrative review.…

1st October 20191st October 2019Immo Weichert

Prevalence of anxiety in people with epilepsy

This is a study from 2017 that used data from the Neurological Disease and Depression Study. [1] Of the total sample (n = 250 patients), nearly 40.0% of participants had anxiety according to the Hospital Anxiety and Depression Scale. The most prevalent symptom of anxiety was “worrying thoughts” (35.6%). After adjustment for age and sex,…

1st October 20192nd October 2019Immo Weichert

The prevalence of anxiety in patients with COPD

This is a systematic review that was published in 2013. [1] 10 studies met the inclusion criteria for review. The studies had small to modest sample sizes and included mainly male COPD patients (71% male). The prevalence of clinical anxiety ranged from 10–55% among in-patients and 13–46% among out-patients with COPD. The authors further describe…

1st October 20192nd October 2019Immo Weichert

COPD increases the risk of depression. Depression and anxiety adversely affect prognosis in COPD, leading to an increased risk of exacerbation and possibly death.

This is a systematic review and meta-analysis that was published in Chest in 2013. [1] It included 16 studies on depression or anxiety as predictors of COPD outcomes (incident COPD/chronic lung disease or exacerbation) and/or mortality, in 28,759 participants followed for 1 to 8 years, and six studies on COPD as a predictor of depression…